Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia

Summary

This is a phase 2, single-center, single-arm, open-label trial. Simon's two-stage design is performed to evaluate the efficacy of low-dose Decitabine in refractory aplastic anemia.

Timeline

Start

2021-04-22

Primary completion

2022-07-26

Completion

2022-08-09

Outcome

Outcome not reported

Stopped: “Not achieve the desired effect”

Drugs

Indications